Developer docs
API playgroundTry for free, no card

Search company profiles

The Colossal Foundation

Full company profile

uuid000unwz

Namestring
The Colossal Foundation
Legal namestring
The Colossal Foundation
Company typeenum
Private
Founded yearint
2024
Descriptiontext

The Colossal Foundation is a 501(c)(3) nonprofit organization established in 2024 and headquartered in Dallas, Texas, that serves as the conservation arm of Colossal Biosciences. It deploys breakthrough bioscience — CRISPR gene editing, ancient DNA assembly, advanced reproductive biology, AI-powered bioacoustics, drone-based computer vision, and cryopreservation biobanking — to partner-led conservation initiatives targeting critically endangered and "lost" species across six continents and 12+ countries. Its operations are organized around three interconnected programs: Saving Today's at Risk Species (genetic rescue for species such as the northern white rhino, red wolf, pink pigeon, and northern quoll), Vital R&D for Conservation (AI and biotechnology for wildlife monitoring), and Ensuring Tomorrow's Biodiversity (the Colossal BioVault and Species Reintroduction Fund). The Foundation supports roughly 24 active projects, has produced landmark outcomes including the first cloned American Red Wolf (Neka Kayda), 81 Victorian Grassland Earless Dragon hatchlings, 29 viable northern white rhino embryos, and 150+ free-ranging Bolson tortoises.

The Foundation's core "products" are grant-funded technology deployments rather than commercial offerings: the Colossal BioVault (the world's largest distributed biobank, anchored by the Colossal 100 prioritized species list and reference genomes), the Species Reintroduction Fund ($250,000 annually in partnership with Re:wild), and program-specific platforms such as the AI wolf bioacoustics pipeline (GrizCam, >92% individual howl identification accuracy), elephant drone-ML tracking, orphan-elephant reintroduction analytics, EEHV mRNA/protein subunit/monoclonal antibody vaccine development with Baylor College of Medicine, cane-toad toxin resistance engineering via iPSCs and CRISPR, and chytrid fungus antibody engineering in amphibians. Underlying technical differentiators include multiplex gene editing pipelines, primordial germ cell (PGC) culturing for avian genetic rescue, museum-specimen ancient-DNA reconstruction, and modular ML pipelines that ingest bioacoustic, video, and genomic data with minimal human intervention.

The Foundation's revenue model is philanthropic rather than commercial: it is funded by grants, donations, and direct capital from Colossal Biosciences, with total capital raised of $100 million as of December 2025 ($50M initial tranche plus an additional $50M raised in December 2025). It does not sell products or services; instead, it flows technology, funding, and in-kind scientific expertise to a network of 20+ conservation NGOs, zoos, universities, and Indigenous communities through direct grant partnerships. Named large commitments include $3M over three years for chytrid research, $500K over ten years to the Nez Perce Tribe for condor reintroduction, $500K for Bolson Tortoise restoration, and $250K annually to the Species Reintroduction Fund. GTM motion is community-led and relationship-driven, with earned media coverage (Yahoo, Wired, CNN, The Guardian, Forbes, Axios, New Scientist) and an inaugural 2025 Impact Report as the primary awareness channels.

Short descriptiontext

The Colossal Foundation is a 501(c)(3) nonprofit that deploys Colossal Biosciences' gene-editing, AI bioacoustics, and biobanking tools to partner-led conservation initiatives across six continents, funding 24 active projects targeting critically endangered species.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersDallas, United States
HQ citystring
Dallas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
conservation biotechnology, species genetic rescue, wildlife biobanking, biodiversity conservation grants, de-extinction research
Industry3 codes
PRIMARYBPAGAGAB
Wildlife Conservation & Species Protection
Business & Public Services/Nonprofit, NGO & Social Services/Environmental & Conservation Organizations
SECONDARYBPAGAKAI
Research & Science Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYEUAHAHAM
Environmental DNA (eDNA) & Advanced Biodiversity Methods (Bioacoustics, Camera Traps)
Energy, Utilities & Environment/Environmental Compliance, Monitoring & Consulting/Ecology, Biodiversity & Natural Resource Assessments
NAICS code1 code
  • Grantmaking Foundations813211
Product category
Wildlife Conservation Biotechnology / De-extinction Nonprofit
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Grants and Donations
TypeSubscription Recurring
Description

The Colossal Foundation operates as a 501(c)(3) nonprofit organization. Its primary revenue comes from grants, donations, and philanthropic funding. It recently doubled its capital to $100 million through an additional $50 million funding round. The foundation deploys funds as grants to conservation partners globally.

colossalfoundation.org
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Personnel, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Colossal Foundation is a 501(c)(3) nonprofit conservation organization that grants funding, deploys proprietary bioscience tools (CRISPR gene editing, AI bioacoustics, cryopreservation biobanking, reproductive technologies), and partners directly with conservation NGOs, universities, Indigenous communities, zoos, and government agencies to deliver genetic rescue, wildlife monitoring, species reintroduction, and ecosystem restoration projects for critically endangered and extinct species across six continents.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • Produced Neka Kayda, the first cloned American Red Wolf — a clone of a ghost wolf with 70.8% Red Wolf ancestry — a world-first conservation cloning milestone
+8 more records
Product overview1 text field

The Colossal Foundation is a 501(c)(3) nonprofit conservation organization that serves as the nonprofit arm of Colossal Biosciences, focused on deploying breakthrough bioscience tools to prevent mass extinctions. The organization operates across three interconnected program areas: Saving Today's at Risk Species (genetic rescue initiatives for critically endangered species), Vital R&D for Conservation (AI and biotechnology development for wildlife monitoring), and Ensuring Tomorrow's Biodiversity (biobanking through the Colossal BioVault and species reintroduction via the Species Reintroduction Fund). Key products include the Colossal BioVault (the world's largest distributed biobanking initiative), the Species Reintroduction Fund ($250,000 annual commitment for rewilding), AI-powered bioacoustic monitoring systems for wolf and bird detection, drone-based elephant behavior tracking, genetic rescue programs for Northern White Rhinos, Red Wolves, and Pink Pigeons, EEHV vaccine development for elephants, cane toad resistance engineering for Northern Quolls, and amphibian chytrid fungus immunity engineering. The foundation supports 24 active conservation projects across six continents.

Product and service4 records
1Colossal Foundation Conservation Programs
CategoryConservation Programs
Description

Three interconnected program areas serving conservation partners: (1) Saving Today's at Risk Species — genetic rescue for critically endangered species; (2) Vital R&D for Conservation — AI, machine learning, and computational biology for wildlife monitoring; (3) Ensuring Tomorrow's Biodiversity — biobanking and species reintroduction.

2Colossal BioVault
CategoryBiobanking & Genetic Preservation
Description

The world's largest distributed biobank initiative preserving genetic diversity of Earth's biosphere through cryopreserved DNA, tissues, reproductive cells, and reference genomes, starting with the Colossal 100 most endangered vertebrate species.

3Species Reintroduction Fund
CategoryGrant Fund / Rewilding
Description

Annual $250,000 fund supporting global species reintroduction and rewilding initiatives, providing funding, genetic tools, technologies, and organizational support to conservation partners worldwide in partnership with Re:wild.

42025 Impact Report
CategoryAnnual Impact Report
Description

Inaugural Impact Report documenting the Foundation's 2025 conservation milestones, project outcomes, and species recovery metrics across its three program areas.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership28 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Colossal Foundation is the official 501(c)(3) nonprofit arm of Colossal Biosciences, the world's first de-extinction and species preservation company. United in the mission to make extinction a thing of the past, the foundation exists to bring Colossal's breakthrough science out of the lab and into the field. The foundation flows technological advancements — including gene editing, biobanking, and AI monitoring — to partner-led conservation initiatives globally.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Colossal Foundation and BioRescue partnered to save the northern white rhino from complete extinction. BioRescue has spent 25+ years collecting oocytes from the last two rhinos (Fatu and Najin) and created 29 viable embryos. Colossal provides genetic rescue technology to restore lost genetic diversity from museum specimens, develop gene editing tools for cell lines, and generate reference genomes. Prof. Dr. Thomas Hildebrandt leads the BioRescue team.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with IPB University for Sumatran Rhino conservation. Colossal facilitated a pivotal three-day summit in March 2023 with global Sumatran rhino conservation stakeholders in Dallas. IPB provides local scientific expertise and leadership in Indonesia's national conservation breeding program, with Colossal providing funding, ART technologies, and genetic sequencing support.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Re:wild, co-founded by Leonardo DiCaprio, is partnered with Colossal Foundation on Sumatran Rhino conservation and co-manages the Species Reintroduction Fund. Re:wild brings global reach in rewilding initiatives and works with Indigenous peoples and local communities.

5Elephant Havens Wildlife Foundation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Colossal Foundation partnered with Elephant Havens, the only elephant orphanage in Botswana, to establish a new model for reintroducing orphan elephants using AI to study and compare behaviors of orphaned and wild elephants. Colossal deploys machine learning algorithms to analyze video data for herd dynamics insights and conducts genomic sequencing on all elephants at the facility.

colossalfoundation.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Elephant Drone Behavior Tracking collaboration between Colossal Foundation and Save the Elephants (November 2023 – May 2026). Drones equipped with high-resolution and infrared cameras collect behavioral data on African elephants; machine learning algorithms analyze movements and social interactions. Fritz Vollrath, Chairman of Save the Elephants, leads the research.

Strategic tierCoreTypeTechnology or Integration
Description

Colossal Foundation collaborates with Dr. Paul Ling, world's leading EEHV researcher at Baylor College of Medicine, to develop mRNA vaccines, protein subunit vaccines, and monoclonal antibody treatments for Elephant Endotheliotropic Herpes Virus — the leading cause of death in juvenile elephants in zoos and the wild.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Colossal Foundation collaborates with the University of Melbourne's TIGRR Lab (headed by Prof. Andrew Pask, Colossal Scientific Advisor) to engineer cane toad toxin resistance in Northern Quolls using CRISPR gene editing and induced pluripotent stem cells. Successfully validated approach in fat-tailed dunnart cells using genetic features from natural toad predators.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Mauritian Wildlife Foundation for Pink Pigeon genetic rescue. Using DNA preserved in museum specimens, Colossal's gene editing tools (originally developed for dodo de-extinction) are applied to restore lost genetic variations into today's pink pigeon population via primordial germ cell culturing and surrogate parent techniques.

10Gulf Coast Canine Project (Dr. Kristin Brzeski & Dr. Bridgett vonHoldt)
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

The Ghost Wolf Genetic Rescue Initiative is co-led by Dr. Kristin Brzeski (Michigan Tech) and Dr. Bridgett vonHoldt (Princeton University). Their field expertise and genomic analyses discovered the ghost wolf — a wild canid carrying high proportions of ancestral Red Wolf DNA. The project combines their academic research with Colossal's cloning and gene editing capabilities to produce Neka Kayda, the first cloned red wolf.

colossalfoundation.org
11Karankawa Tribe of Texas
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Karankawa Tribe of Texas is a cultural and community partner in the Ghost Wolf Genetic Rescue Initiative. The tribe's ancestral connection to the Gulf Coast and the red wolf is honored in the project naming (Neka Kadya/Kayda). The partnership exemplifies community-led conservation that respects Indigenous knowledge and sovereignty.

colossalfoundation.org
12American Wolf Foundation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner organization in the Ghost Wolf Genetic Rescue Initiative and red wolf conservation efforts, contributing expertise in wolf management and habitat restoration.

colossalfoundation.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Colossal Foundation supports the Yellowstone Wolf Project through a bioacoustics initiative in partnership with Yellowstone Forever, the official nonprofit partner of Yellowstone National Park. The project deploys GrizCam acoustic/video traps across the Greater Yellowstone Ecosystem to monitor wolf populations using AI, with data analyzed by Colossal's AI team.

14Grizzly Systems Inc.
Strategic tierCoreTypeTechnology or Integration
Description

Grizzly Systems Inc. (founders Cody Goldhahn and Jeff Reed) developed the GrizCam — an integrated acoustic and video camera trap. The company has been developing advanced camera trap solutions with built-in acoustic recorders. Colossal Foundation's support funded 25 additional GrizCam units for deployment in Yellowstone and on Nez Perce tribal lands.

colossalfoundation.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Nez Perce Tribe's Wildlife Division partners with Colossal Foundation on two initiatives: (1) California Condor reintroduction to ancestral Nez Perce lands ($500,000 ten-year commitment) and (2) a pilot deployment of GrizCam acoustic monitoring on tribal lands to track wolf packs, combining bioacoustic technology with the tribe's on-the-ground expertise and traditional ecological knowledge.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Yurok Tribe is a partner in the Camas to Condors (C2C) coalition working on California condor recovery alongside the Nez Perce Tribe, U.S. Fish and Wildlife Service, and other organizations.

17Instituto de Pesquisas Ecológicas (IPÊ)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

IPÊ (Brazilian Institute for Ecological Research), with support from the Colossal Foundation's Species Reintroduction Fund, leads black lion tamarin conservation through population management, habitat restoration of 2,000 acres, and community engagement in São Paulo's Pontal do Paranapanema region. Over 40 years of leadership has improved the species' status from Critically Endangered to Endangered.

colossalfoundation.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

TESF leads Bolson Tortoise rewilding in New Mexico, with Colossal Foundation providing $500,000 for juvenile releases, monitoring of 150+ free-ranging tortoises, and publishing rewilding protocols. TESF bred and released the first U.S.-born Bolson tortoises in over 10,000 years.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

UMSNH leads the Golden Skiffia reintroduction project in Mexico's Teuchitlán River, with support from the Species Reintroduction Fund. The project also targets the banded allotoca and Ameca shiner (both Extinct-in-the-Wild). Colossal Foundation supports river restoration, hatchery expansion (2,000+ individuals per species), and community engagement.

20Viet Nature Conservation Centre & Zoological Society of London (ZSL)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Viet Nature (local NGO) and ZSL (global conservation charity operating London Zoo and Whipsnade Zoo) lead Vietnam Pheasant reintroduction to protected forest reserves in Quang Binh Province. The project includes expansion of the Rare Pheasant Breeding Centre, translocation planning workshop, and operational support, with Colossal Foundation funding accelerating mission-critical steps.

colossalfoundation.org
21Centro Jambatu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Centro Jambatu, Ecuador's leading amphibian research and conservation center, leads the Wampukrum Harlequin Frog reintroduction in the Ecuadorian Amazon. With Colossal Foundation support (June 2025 – May 2026), the project aims to breed at least 6 egg clutches and release 800+ tadpoles, juveniles, and adults to Morona Santiago Province.

colossalfoundation.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Zoos Victoria leads the Victorian Grassland Earless Dragon conservation breeding program at Melbourne Zoo, with Colossal Foundation providing funding for interim quarantine housing, genome sequencing, and genetic relatedness mapping. From 39 rediscovered individuals, 11 breeding pairs produced 81 hatchlings.

23Samoa Conservation Society, BirdLife International & IUCN SSC Pigeon and Dove Specialist Group
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to locate the lost tooth-billed pigeon ('little dodo') using AI-powered bioacoustic monitoring. AI algorithms are being developed to detect and identify tooth-billed pigeon calls from microphones deployed in Samoan forests, with real-time alerts to conservation authorities.

colossalfoundation.org
24Dr. Frankenberg & Dr. Pask Research Team
Strategic tierCoreTypeTechnology or Integration
Description

Colossal Foundation committed $3 million over three years to support chytrid fungus immunity engineering research. Initial work uses the invasive cane toad as a model species to test and refine the approach. Once validated, technology will be applied to critically endangered Australian amphibians (great spotted tree frog, green and golden bell frog, corroboree frog).

colossalfoundation.org
25Houston Zoo
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Houston Zoo participates in Dr. Paul Ling's 'Bench to Barn' EEHV research program, which focuses on diagnostics, treatments, and vaccine development. The zoo's elephant program provides clinical context for the vaccine development effort.

colossalfoundation.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Conservation partner listed on the Colossal Foundation Partners page, focused on conservation efforts.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Rewilding is a conservation partner supporting Sumatran rhino efforts and broader rewilding initiatives.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in the Colossal BioVault initiative, contributing to reference genome generation for the Colossal 100 prioritized species list.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1IUCN (International Union for Conservation of Nature)
TypeOthers
TypeBroad incumbent
Description

Operates the Frozen Zoo, the world's most established cryopreserved biobank, and runs major conservation breeding and reintroduction programs. Directly comparable through biobanking infrastructure (analog to Colossal BioVault) and species recovery work in similar vertebrate taxa.

TypeDirect peer
Description

Global rewilding nonprofit co-founded by Leonardo DiCaprio that partners with the Colossal Foundation on the Species Reintroduction Fund. Directly comparable in species reintroduction, ecosystem restoration focus, and Indigenous community partnership model across similar geographies.

TypeBroad incumbent
Description

Major global conservation NGO with significant funding flows and species-focused field programs. Comparable in conservation grantmaking scale, geographic reach, and partnership-driven reintroduction model across similar threatened species.

TypeBroad incumbent
Description

One of the world's largest environmental nonprofits with multi-billion-dollar annual revenue and a strong land/habitat conservation focus. Comparable scale of grantmaking, multi-continent footprint, and conservation partnership model, though less biotech-oriented.

6Zoological Society of London (ZSL)
TypeBroad incumbent
Description

International conservation charity operating London Zoo and Whipsnade Zoo with active field programs in species recovery. Directly comparable as a partner (Vietnam Pheasant, Sumatran Rhino) and in zoo-based conservation breeding and reintroduction methodology.

TypeBroad incumbent
Description

Major global conservation NGO operating zoos and field programs across 100+ countries with a $500M+ budget. Comparable in species-focused conservation grantmaking, field partnership model, and global multi-continent footprint, though without biotech R&D focus.

8World Wildlife Fund (WWF)
TypeBroad incumbent
Description

The largest global conservation NGO, operating species programs across all continents with multi-billion-dollar funding flows. Comparable as a global species conservation grantmaker with similar target species (rhinos, elephants, big cats) and partnership ecosystem.

9Panthera
TypeBroad incumbent
Description

Global wild cat conservation NGO focused on species-level recovery, anti-poaching, and reintroduction. Comparable in species-specific focus, field-driven grantmaking, and partnership model with Indigenous and local community stakeholders in similar geographies.

TypeDirect peer
Description

The leading nonprofit applying genetic rescue and biotechnology to species conservation, including de-extinction-adjacent work. Directly comparable to the Colossal Foundation in mission (biotech-driven conservation), use of CRISPR and ancient DNA, and species focus (passenger pigeon, black-footed ferret).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers21 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability20 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature14 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Colossal Foundation

Wildlife Conservation Biotechnology / De-extinction Nonprofitcolossalfoundation.org

The Colossal Foundation is a 501(c)(3) nonprofit that deploys Colossal Biosciences' gene-editing, AI bioacoustics, and biobanking tools to partner-led conservation initiatives across six continents, funding 24 active projects targeting critically endangered species.

What The Colossal Foundation does

The Colossal Foundation is a 501(c)(3) nonprofit organization established in 2024 and headquartered in Dallas, Texas, that serves as the conservation arm of Colossal Biosciences. It deploys breakthrough bioscience — CRISPR gene editing, ancient DNA assembly, advanced reproductive biology, AI-powered bioacoustics, drone-based computer vision, and cryopreservation biobanking — to partner-led conservation initiatives targeting critically endangered and "lost" species across six continents and 12+ countries. Its operations are organized around three interconnected programs: Saving Today's at Risk Species (genetic rescue for species such as the northern white rhino, red wolf, pink pigeon, and northern quoll), Vital R&D for Conservation (AI and biotechnology for wildlife monitoring), and Ensuring Tomorrow's Biodiversity (the Colossal BioVault and Species Reintroduction Fund). The Foundation supports roughly 24 active projects, has produced landmark outcomes including the first cloned American Red Wolf (Neka Kayda), 81 Victorian Grassland Earless Dragon hatchlings, 29 viable northern white rhino embryos, and 150+ free-ranging Bolson tortoises.

The Foundation's core "products" are grant-funded technology deployments rather than commercial offerings: the Colossal BioVault (the world's largest distributed biobank, anchored by the Colossal 100 prioritized species list and reference genomes), the Species Reintroduction Fund ($250,000 annually in partnership with Re:wild), and program-specific platforms such as the AI wolf bioacoustics pipeline (GrizCam, >92% individual howl identification accuracy), elephant drone-ML tracking, orphan-elephant reintroduction analytics, EEHV mRNA/protein subunit/monoclonal antibody vaccine development with Baylor College of Medicine, cane-toad toxin resistance engineering via iPSCs and CRISPR, and chytrid fungus antibody engineering in amphibians. Underlying technical differentiators include multiplex gene editing pipelines, primordial germ cell (PGC) culturing for avian genetic rescue, museum-specimen ancient-DNA reconstruction, and modular ML pipelines that ingest bioacoustic, video, and genomic data with minimal human intervention.

The Foundation's revenue model is philanthropic rather than commercial: it is funded by grants, donations, and direct capital from Colossal Biosciences, with total capital raised of $100 million as of December 2025 ($50M initial tranche plus an additional $50M raised in December 2025). It does not sell products or services; instead, it flows technology, funding, and in-kind scientific expertise to a network of 20+ conservation NGOs, zoos, universities, and Indigenous communities through direct grant partnerships. Named large commitments include $3M over three years for chytrid research, $500K over ten years to the Nez Perce Tribe for condor reintroduction, $500K for Bolson Tortoise restoration, and $250K annually to the Species Reintroduction Fund. GTM motion is community-led and relationship-driven, with earned media coverage (Yahoo, Wired, CNN, The Guardian, Forbes, Axios, New Scientist) and an inaugural 2025 Impact Report as the primary awareness channels.

The Colossal Foundation firmographics

Firmographics
Name
The Colossal Foundation
Legal name
The Colossal Foundation
Website
https://colossalfoundation.org
Company type
Private
Founded year
2024
Operating status
Operating
Short description
The Colossal Foundation is a 501(c)(3) nonprofit that deploys Colossal Biosciences' gene-editing, AI bioacoustics, and biobanking tools to partner-led conservation initiatives across six continents, funding 24 active projects targeting critically endangered species.
Ownership category
akta.pro rank

The Colossal Foundation industry classification

Industry
Product category
Wildlife Conservation Biotechnology / De-extinction Nonprofit
NAICS
Grantmaking Foundations (813211)
akta.pro industry
PRIMARYBPAGAGAB
Wildlife Conservation & Species Protection
Business & Public Services/Nonprofit, NGO & Social Services/Environmental & Conservation Organizations
SECONDARYBPAGAKAI
Research & Science Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYEUAHAHAM
Environmental DNA (eDNA) & Advanced Biodiversity Methods (Bioacoustics, Camera Traps)
Energy, Utilities & Environment/Environmental Compliance, Monitoring & Consulting/Ecology, Biodiversity & Natural Resource Assessments

Keywords

  • Conservation biotechnology
  • Species genetic rescue
  • Wildlife biobanking
  • Biodiversity conservation grants
  • De-extinction research

Where The Colossal Foundation is headquartered

Location

Headquarters

HQ city
Dallas
HQ country
United States
HQ region
North America

Offices1 record

Markets served

The Colossal Foundation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Operations, Personnel, Marketing or Sales, Others

Revenue model

  1. Grants and Donations: The Colossal Foundation operates as a 501(c)(3) nonprofit organization. Its primary revenue comes from grants, donations, and philanthropic funding. It recently doubled its capital to $100 million through an additional $50 million funding round. The foundation deploys funds as grants to conservation partners globally.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

The Colossal Foundation product offering

Product offering

Core offering

The Colossal Foundation is a 501(c)(3) nonprofit conservation organization that grants funding, deploys proprietary bioscience tools (CRISPR gene editing, AI bioacoustics, cryopreservation biobanking, reproductive technologies), and partners directly with conservation NGOs, universities, Indigenous communities, zoos, and government agencies to deliver genetic rescue, wildlife monitoring, species reintroduction, and ecosystem restoration projects for critically endangered and extinct species across six continents.

Product overview

The Colossal Foundation is a 501(c)(3) nonprofit conservation organization that serves as the nonprofit arm of Colossal Biosciences, focused on deploying breakthrough bioscience tools to prevent mass extinctions. The organization operates across three interconnected program areas: Saving Today's at Risk Species (genetic rescue initiatives for critically endangered species), Vital R&D for Conservation (AI and biotechnology development for wildlife monitoring), and Ensuring Tomorrow's Biodiversity (biobanking through the Colossal BioVault and species reintroduction via the Species Reintroduction Fund). Key products include the Colossal BioVault (the world's largest distributed biobanking initiative), the Species Reintroduction Fund ($250,000 annual commitment for rewilding), AI-powered bioacoustic monitoring systems for wolf and bird detection, drone-based elephant behavior tracking, genetic rescue programs for Northern White Rhinos, Red Wolves, and Pink Pigeons, EEHV vaccine development for elephants, cane toad resistance engineering for Northern Quolls, and amphibian chytrid fungus immunity engineering. The foundation supports 24 active conservation projects across six continents.

Differentiator

Problem solved

Functional benefit

Products and services

  • Colossal Foundation Conservation Programs Three interconnected program areas serving conservation partners: (1) Saving Today's at Risk Species — genetic rescue for critically endangered species; (2) Vital R&D for Conservation — AI, machine learning, and computational biology for wildlife monitoring; (3) Ensuring Tomorrow's Biodiversity — biobanking and species reintroduction.
  • Colossal BioVault The world's largest distributed biobank initiative preserving genetic diversity of Earth's biosphere through cryopreserved DNA, tissues, reproductive cells, and reference genomes, starting with the Colossal 100 most endangered vertebrate species.
  • Species Reintroduction Fund Annual $250,000 fund supporting global species reintroduction and rewilding initiatives, providing funding, genetic tools, technologies, and organizational support to conservation partners worldwide in partnership with Re:wild.
  • 2025 Impact Report Inaugural Impact Report documenting the Foundation's 2025 conservation milestones, project outcomes, and species recovery metrics across its three program areas.

Quantifiable outcome

  • Produced Neka Kayda, the first cloned American Red Wolf — a clone of a ghost wolf with 70.8% Red Wolf ancestry — a world-first conservation cloning milestone
  • +8 more outcomes

Companies that use The Colossal Foundation

Customer profile

Named customers21 records

Segments4 records

Ideal customer profiles4 records

The Colossal Foundation technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability20 records

Feature14 records

The Colossal Foundation partnerships and signals

Strategic signal

Partnerships

28 partnerships are on record, tiered core, flagship and minor.

  • Colossal BiosciencescoreStrategic or Co-development PartnerThe Colossal Foundation is the official 501(c)(3) nonprofit arm of Colossal Biosciences, the world's first de-extinction and species preservation company. United in the mission to make extinction a thing of the past, the foundation exists to bring Colossal's breakthrough science out of the lab and into the field. The foundation flows technological advancements — including gene editing, biobanking, and AI monitoring — to partner-led conservation initiatives globally.
  • BioRescue Consortium (Leibniz Institute for Zoo and Wildlife Research, Ol Pejeta Conservancy, Dvůr Králové Zoo)flagshipStrategic or Co-development PartnerColossal Foundation and BioRescue partnered to save the northern white rhino from complete extinction. BioRescue has spent 25+ years collecting oocytes from the last two rhinos (Fatu and Najin) and created 29 viable embryos. Colossal provides genetic rescue technology to restore lost genetic diversity from museum specimens, develop gene editing tools for cell lines, and generate reference genomes. Prof. Dr. Thomas Hildebrandt leads the BioRescue team.
  • IPB University (Institut Pertanian Bogor)coreStrategic or Co-development PartnerPartnership with IPB University for Sumatran Rhino conservation. Colossal facilitated a pivotal three-day summit in March 2023 with global Sumatran rhino conservation stakeholders in Dallas. IPB provides local scientific expertise and leadership in Indonesia's national conservation breeding program, with Colossal providing funding, ART technologies, and genetic sequencing support.
  • Re:wildcoreStrategic or Co-development PartnerRe:wild, co-founded by Leonardo DiCaprio, is partnered with Colossal Foundation on Sumatran Rhino conservation and co-manages the Species Reintroduction Fund. Re:wild brings global reach in rewilding initiatives and works with Indigenous peoples and local communities.
  • Elephant Havens Wildlife FoundationcoreStrategic or Co-development PartnerColossal Foundation partnered with Elephant Havens, the only elephant orphanage in Botswana, to establish a new model for reintroducing orphan elephants using AI to study and compare behaviors of orphaned and wild elephants. Colossal deploys machine learning algorithms to analyze video data for herd dynamics insights and conducts genomic sequencing on all elephants at the facility.
  • Save the ElephantscoreStrategic or Co-development PartnerElephant Drone Behavior Tracking collaboration between Colossal Foundation and Save the Elephants (November 2023 – May 2026). Drones equipped with high-resolution and infrared cameras collect behavioral data on African elephants; machine learning algorithms analyze movements and social interactions. Fritz Vollrath, Chairman of Save the Elephants, leads the research.
  • Baylor College of Medicine (Dr. Paul Ling)coreTechnology or IntegrationColossal Foundation collaborates with Dr. Paul Ling, world's leading EEHV researcher at Baylor College of Medicine, to develop mRNA vaccines, protein subunit vaccines, and monoclonal antibody treatments for Elephant Endotheliotropic Herpes Virus — the leading cause of death in juvenile elephants in zoos and the wild.
  • University of Melbourne (TIGRR Lab / Prof. Andrew Pask)coreStrategic or Co-development PartnerColossal Foundation collaborates with the University of Melbourne's TIGRR Lab (headed by Prof. Andrew Pask, Colossal Scientific Advisor) to engineer cane toad toxin resistance in Northern Quolls using CRISPR gene editing and induced pluripotent stem cells. Successfully validated approach in fat-tailed dunnart cells using genetic features from natural toad predators.
  • Mauritian Wildlife FoundationcoreStrategic or Co-development PartnerPartnership with Mauritian Wildlife Foundation for Pink Pigeon genetic rescue. Using DNA preserved in museum specimens, Colossal's gene editing tools (originally developed for dodo de-extinction) are applied to restore lost genetic variations into today's pink pigeon population via primordial germ cell culturing and surrogate parent techniques.
  • Gulf Coast Canine Project (Dr. Kristin Brzeski & Dr. Bridgett vonHoldt)flagshipStrategic or Co-development PartnerThe Ghost Wolf Genetic Rescue Initiative is co-led by Dr. Kristin Brzeski (Michigan Tech) and Dr. Bridgett vonHoldt (Princeton University). Their field expertise and genomic analyses discovered the ghost wolf — a wild canid carrying high proportions of ancestral Red Wolf DNA. The project combines their academic research with Colossal's cloning and gene editing capabilities to produce Neka Kayda, the first cloned red wolf.
  • Karankawa Tribe of TexascoreStrategic or Co-development PartnerThe Karankawa Tribe of Texas is a cultural and community partner in the Ghost Wolf Genetic Rescue Initiative. The tribe's ancestral connection to the Gulf Coast and the red wolf is honored in the project naming (Neka Kadya/Kayda). The partnership exemplifies community-led conservation that respects Indigenous knowledge and sovereignty.
  • American Wolf FoundationcoreStrategic or Co-development PartnerPartner organization in the Ghost Wolf Genetic Rescue Initiative and red wolf conservation efforts, contributing expertise in wolf management and habitat restoration.
  • Yellowstone ForevercoreStrategic or Co-development PartnerColossal Foundation supports the Yellowstone Wolf Project through a bioacoustics initiative in partnership with Yellowstone Forever, the official nonprofit partner of Yellowstone National Park. The project deploys GrizCam acoustic/video traps across the Greater Yellowstone Ecosystem to monitor wolf populations using AI, with data analyzed by Colossal's AI team.
  • Grizzly Systems Inc.coreTechnology or IntegrationGrizzly Systems Inc. (founders Cody Goldhahn and Jeff Reed) developed the GrizCam — an integrated acoustic and video camera trap. The company has been developing advanced camera trap solutions with built-in acoustic recorders. Colossal Foundation's support funded 25 additional GrizCam units for deployment in Yellowstone and on Nez Perce tribal lands.
  • Nez Perce Tribe Wildlife DivisioncoreStrategic or Co-development PartnerThe Nez Perce Tribe's Wildlife Division partners with Colossal Foundation on two initiatives: (1) California Condor reintroduction to ancestral Nez Perce lands ($500,000 ten-year commitment) and (2) a pilot deployment of GrizCam acoustic monitoring on tribal lands to track wolf packs, combining bioacoustic technology with the tribe's on-the-ground expertise and traditional ecological knowledge.
  • Yurok TribeminorStrategic or Co-development PartnerYurok Tribe is a partner in the Camas to Condors (C2C) coalition working on California condor recovery alongside the Nez Perce Tribe, U.S. Fish and Wildlife Service, and other organizations.
  • Instituto de Pesquisas Ecológicas (IPÊ)coreStrategic or Co-development PartnerIPÊ (Brazilian Institute for Ecological Research), with support from the Colossal Foundation's Species Reintroduction Fund, leads black lion tamarin conservation through population management, habitat restoration of 2,000 acres, and community engagement in São Paulo's Pontal do Paranapanema region. Over 40 years of leadership has improved the species' status from Critically Endangered to Endangered.
  • Turner Endangered Species Fund (TESF)coreStrategic or Co-development PartnerTESF leads Bolson Tortoise rewilding in New Mexico, with Colossal Foundation providing $500,000 for juvenile releases, monitoring of 150+ free-ranging tortoises, and publishing rewilding protocols. TESF bred and released the first U.S.-born Bolson tortoises in over 10,000 years.
  • Universidad Michoacana de San Nicolás de Hidalgo (UMSNH)coreStrategic or Co-development PartnerUMSNH leads the Golden Skiffia reintroduction project in Mexico's Teuchitlán River, with support from the Species Reintroduction Fund. The project also targets the banded allotoca and Ameca shiner (both Extinct-in-the-Wild). Colossal Foundation supports river restoration, hatchery expansion (2,000+ individuals per species), and community engagement.
  • Viet Nature Conservation Centre & Zoological Society of London (ZSL)coreStrategic or Co-development PartnerViet Nature (local NGO) and ZSL (global conservation charity operating London Zoo and Whipsnade Zoo) lead Vietnam Pheasant reintroduction to protected forest reserves in Quang Binh Province. The project includes expansion of the Rare Pheasant Breeding Centre, translocation planning workshop, and operational support, with Colossal Foundation funding accelerating mission-critical steps.
  • Centro JambatucoreStrategic or Co-development PartnerCentro Jambatu, Ecuador's leading amphibian research and conservation center, leads the Wampukrum Harlequin Frog reintroduction in the Ecuadorian Amazon. With Colossal Foundation support (June 2025 – May 2026), the project aims to breed at least 6 egg clutches and release 800+ tadpoles, juveniles, and adults to Morona Santiago Province.
  • Zoos VictoriacoreStrategic or Co-development PartnerZoos Victoria leads the Victorian Grassland Earless Dragon conservation breeding program at Melbourne Zoo, with Colossal Foundation providing funding for interim quarantine housing, genome sequencing, and genetic relatedness mapping. From 39 rediscovered individuals, 11 breeding pairs produced 81 hatchlings.
  • Samoa Conservation Society, BirdLife International & IUCN SSC Pigeon and Dove Specialist GroupcoreStrategic or Co-development PartnerPartnership to locate the lost tooth-billed pigeon ('little dodo') using AI-powered bioacoustic monitoring. AI algorithms are being developed to detect and identify tooth-billed pigeon calls from microphones deployed in Samoan forests, with real-time alerts to conservation authorities.
  • Dr. Frankenberg & Dr. Pask Research TeamcoreTechnology or IntegrationColossal Foundation committed $3 million over three years to support chytrid fungus immunity engineering research. Initial work uses the invasive cane toad as a model species to test and refine the approach. Once validated, technology will be applied to critically endangered Australian amphibians (great spotted tree frog, green and golden bell frog, corroboree frog).
  • Houston ZoominorStrategic or Co-development PartnerHouston Zoo participates in Dr. Paul Ling's 'Bench to Barn' EEHV research program, which focuses on diagnostics, treatments, and vaccine development. The zoo's elephant program provides clinical context for the vaccine development effort.
  • Conservation NationminorStrategic or Co-development PartnerConservation partner listed on the Colossal Foundation Partners page, focused on conservation efforts.
  • RewildingminorStrategic or Co-development PartnerRewilding is a conservation partner supporting Sumatran rhino efforts and broader rewilding initiatives.
  • Vertebrate Genomes ProjectminorStrategic or Co-development PartnerPartner in the Colossal BioVault initiative, contributing to reference genome generation for the Colossal 100 prioritized species list.

Scale indicators11 records

Recent moves7 records

Expansion highlights6 records

The Colossal Foundation competitors and assessment

Company assessment

Others

  • IUCN (International Union for Conservation of Nature):

Broad incumbents

  • San Diego Zoo Wildlife Alliance: Operates the Frozen Zoo, the world's most established cryopreserved biobank, and runs major conservation breeding and reintroduction programs. Directly comparable through biobanking infrastructure (analog to Colossal BioVault) and species recovery work in similar vertebrate taxa.
  • Conservation International: Major global conservation NGO with significant funding flows and species-focused field programs. Comparable in conservation grantmaking scale, geographic reach, and partnership-driven reintroduction model across similar threatened species.
  • The Nature Conservancy: One of the world's largest environmental nonprofits with multi-billion-dollar annual revenue and a strong land/habitat conservation focus. Comparable scale of grantmaking, multi-continent footprint, and conservation partnership model, though less biotech-oriented.
  • Zoological Society of London (ZSL): International conservation charity operating London Zoo and Whipsnade Zoo with active field programs in species recovery. Directly comparable as a partner (Vietnam Pheasant, Sumatran Rhino) and in zoo-based conservation breeding and reintroduction methodology.
  • Wildlife Conservation Society: Major global conservation NGO operating zoos and field programs across 100+ countries with a $500M+ budget. Comparable in species-focused conservation grantmaking, field partnership model, and global multi-continent footprint, though without biotech R&D focus.
  • World Wildlife Fund (WWF): The largest global conservation NGO, operating species programs across all continents with multi-billion-dollar funding flows. Comparable as a global species conservation grantmaker with similar target species (rhinos, elephants, big cats) and partnership ecosystem.
  • Panthera: Global wild cat conservation NGO focused on species-level recovery, anti-poaching, and reintroduction. Comparable in species-specific focus, field-driven grantmaking, and partnership model with Indigenous and local community stakeholders in similar geographies.

Direct peers

  • Re:wild: Global rewilding nonprofit co-founded by Leonardo DiCaprio that partners with the Colossal Foundation on the Species Reintroduction Fund. Directly comparable in species reintroduction, ecosystem restoration focus, and Indigenous community partnership model across similar geographies.
  • Revive & Restore: The leading nonprofit applying genetic rescue and biotechnology to species conservation, including de-extinction-adjacent work. Directly comparable to the Colossal Foundation in mission (biotech-driven conservation), use of CRISPR and ancient DNA, and species focus (passenger pigeon, black-footed ferret).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

The Colossal Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Colossal Foundation leadership team

Management profile

Number of profiles

Profiles2 records

The Colossal Foundation funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Colossal Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Colossal Foundation

What does The Colossal Foundation do?

The Colossal Foundation is a 501(c)(3) nonprofit conservation organization that grants funding, deploys proprietary bioscience tools (CRISPR gene editing, AI bioacoustics, cryopreservation biobanking, reproductive technologies), and partners directly with conservation NGOs, universities, Indigenous communities, zoos, and government agencies to deliver genetic rescue, wildlife monitoring, species reintroduction, and ecosystem restoration projects for critically endangered and extinct species across six continents.

Is The Colossal Foundation a public or private company?

The Colossal Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was The Colossal Foundation founded?

The Colossal Foundation was founded in 2024.

Where is The Colossal Foundation based?

The Colossal Foundation is headquartered in Dallas, United States, in the North America region.

How does The Colossal Foundation make money?

One revenue line is on record: grants and Donations.

Who are The Colossal Foundation's main competitors?

IUCN (International Union for Conservation of Nature) is listed as an others. Broad incumbents are San Diego Zoo Wildlife Alliance, Conservation International, The Nature Conservancy, Zoological Society of London (ZSL), Wildlife Conservation Society, World Wildlife Fund (WWF) and Panthera. Direct peers are Re:wild and Revive & Restore.

Does The Colossal Foundation have an API?

No public API is recorded for The Colossal Foundation.

What industry is The Colossal Foundation in?

The Colossal Foundation's product category is Wildlife Conservation Biotechnology / De-extinction Nonprofit. Its primary akta.pro industry code is BPAGAGAB, Wildlife Conservation & Species Protection, with a secondary code of BPAGAKAI, Research & Science Grantmaking Foundations. Its NAICS code is 813211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Dallas InnovatesColossal Foundation, IUCN Launch $4M Species PartnershipThe Colossal Foundation and IUCN Species Survival Commission launched a four-year, $4 million partnership to accelerate species conservation using Colossal Biosciences' technology. The initiative includes a grant program for neglected species and aims to expand the IUCN Red List. The foundation, established in 2024, boosted its funding to $100 million last year.FinancialContent Business PageIUCN Species Survival Commission and Colossal Foundation Launch $4 Million Partnership to Accelerate Global Species ConservationIUCN Species Survival Commission and Colossal Foundation announced a four-year, $4 million partnership to expand advanced technologies in global species conservation. The collaboration pairs over 11,000 IUCN experts with Colossal's scientific capabilities, aiming to modernize Red List assessments, fund overlooked species, and strengthen the global network.Business Wire BlogIUCN Species Survival Commission and Colossal Foundation Launch $4 Million Partnership to Accelerate Global Species ConservationIUCN Species Survival Commission and Colossal Foundation announced a four-year, $4 million partnership to expand advanced technology use in species conservation. The collaboration pairs 11,000+ IUCN experts with Colossal's scientific capabilities, aiming to modernize Red List assessments, fund overlooked species, and strengthen the global network.PR NewswireIUCN Species Survival Commission and Colossal Foundation Launch $4 Million Partnership to Accelerate Global Species ConservationIUCN Species Survival Commission and Colossal Foundation announced a four-year, $4 million partnership to expand conservation technology use. The initiative will modernize Red List assessments, fund overlooked species, and strengthen the global network of over 11,000 experts. The collaboration aims to deploy AI and other tools responsibly while preserving IUCN's scientific independence.FinancialContent Business PageColossal Foundation and Re:wild Expand Species Reintroduction Fund to Seven New Species Across Four ContinentsThe Colossal Foundation has announced the second annual cohort of its Species Reintroduction Fund, expanding the program to seven new species across Cambodia, the United States, Brazil, Guatemala, Australia, and Canada. The fund will direct its annual commitment of $250,000 to conservation teams working on species recovery efforts, while the program has attracted nearly $5 million in partnership requests—roughly twenty times its annual budget. In collaboration with Re:wild, recipients gain access to genetic tools, emerging technologies, training, and support spanning from planning and genetic assessment to release and long-term monitoring.Business Wire BlogColossal Foundation and Re:wild Expand Species Reintroduction Fund to Seven New Species Across Four ContinentsThe Colossal Foundation and Re:wild announced the second cohort of the Species Reintroduction Fund, expanding to seven new species across four continents with an annual commitment of $250,000. The fund, launched in 2025 as the world's first dedicated entirely to wildlife reintroduction and rewilding, received nearly $5 million in partnership requests this cycle—roughly twenty times its annual budget. Conservation teams will work in Cambodia, the United States, Brazil, Guatemala, Australia, and Canada, with projects spanning the banteng, black-footed ferret, brown howler monkey, Campbell's alligator lizard, Guam kingfisher, northern quoll, and sunflower sea star.PR NewswireColossal Foundation and Re:wild Expand Flagship Species Reintroduction Fund to Seven New Species WorldwideThe Colossal Foundation, in collaboration with Re:wild, announced the second cohort of its Species Reintroduction Fund, directing $250,000 to seven conservation projects across four continents. The selected initiatives aim to reintroduce threatened species such as the banteng, black-footed ferret, and sunflower sea star into their native habitats using genetic technologies and habitat restoration.Dallas InnovatesColossal Foundation Partners With Tasmania to Save DevilsThe Colossal Foundation has partnered with the University of Tasmania to combat devil facial tumor disease, a lethal cancer that has reduced wild Tasmanian devil populations by 80% since the 1990s. The partnership will combine a field-ready oral bait vaccine developed by Associate Professor Andrew Flies with Colossal's gene-editing research on the LZTR1 gene to create a two-pronged defense strategy. The collaboration builds on Colossal's existing marsupial biotechnology platform developed through its thylacine de-extinction program.PcdnColossal Foundation Partners With Tasmania to Save DevilsThe Colossal Foundation, the nonprofit arm of Dallas-based Colossal Biosciences, has partnered with the University of Tasmania to combat devil facial tumor disease, a lethal cancer that has decimated the wild Tasmanian devil population by 80% since the 1990s. The partnership employs two strategies: a field-ready oral bait vaccine developed by Associate Professor Andrew Flies' Wild Immunology Group, and gene-editing research targeting the LZTR1 gene linked to tumor origin. The initiative builds on Colossal's marsupial biotechnology platform developed through its thylacine de-extinction program, with plans to establish a fat-tailed dunnart research colony at the Menzies Institute for Medical Research to conduct vaccine safety trials before any trials in devils.ColossalColossal Foundation Targets Devil Facial Tumour DiseaseThe Colossal Foundation and the University of Tasmania have announced a partnership to fight devil facial tumour disease, a contagious cancer that has reduced the wild Tasmanian devil population by approximately 80 percent since 1996. The collaboration combines a field-ready oral vaccine developed by University of Tasmania immunologist Andrew Flies with Colossal's de-extinction technologies and marsupial science, using the fat-tailed dunnart as a test model before treatments reach endangered devils. The same protocols and tools originally developed for the thylacine (Tasmanian tiger) de-extinction program are being redirected to protect a living species from extinction.